Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05245747 · ClinicalTrials.gov registry record
Vitls Feasibility Physiologic Monitoring
A clinical trial of Pediatrics and Remote Monitoring, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05245747: Completed study of Pediatrics and Remote Monitoring, sponsored by Children's Mercy Hospital Kansas City.
NCT05245747 is a study of Pediatrics and Remote Monitoring that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 20 participants, below the 1,341-participant average among 15 other Pediatrics trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05245747, a study of Pediatrics and Remote Monitoring, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
A single site, cross-sectional, feasibility study will be used to evaluate the feasibility of the collection of physiologic data related to the use of the Vitls Platform in the pediatric (\< 2 year of age) congenital heart and general surgery populations in the hospital setting that is using 24 hour a day monitoring for routine care over a 48-hour period. A short questionnaire will be sent electronically for the parent-child dyad feedback after the participating child has worn the device. No data will be available at the time of placement for the Healthcare team and will not replace any routine/standard of care monitoring already in place for this complex population.
Primary Outcome
To evaluate the feasibility of collecting heart rate data with the Vitls Platform
Conditions Studied
Interventions
- DEVICE Vitls Tego Device
Study Locations (1)
Missouri
- Children's Mercy Kansas City - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-02-28 |
| Est. Completion | 2023-05-16 |
What the finished NCT05245747 record still lists
NCT05245747 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,341-participant average among 15 other Pediatrics trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Pediatrics appearing as the primary indexed condition, and to 1 intervention - of which Vitls Tego Device is the first listed.
NCT05245747 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT05245747 about?
NCT05245747 is a clinical study titled "Vitls Feasibility Physiologic Monitoring". A single site, cross-sectional, feasibility study will be used to evaluate the feasibility of the collection of physiologic data related to the use of the Vitls Platform in the pediatric (\< 2 year of age) congenital heart and general surgery populations in the hospital setting that is using 24 hour...
What is the current status of trial NCT05245747?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-02-28. Estimated completion is 2023-05-16.
What conditions does trial NCT05245747 study?
This clinical trial studies the following conditions: Pediatrics, Remote Monitoring, Vital Signs.
What interventions are being tested in trial NCT05245747?
The interventions under investigation include: Vitls Tego Device (DEVICE).
Who is sponsoring clinical trial NCT05245747?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05245747 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatrics
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05245747's enrollment target sits among peer trials
20 14th of 15 higher than 2 of 15 other Pediatrics trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatrics trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Giving Reduced Fluid in Children After Trauma
RECRUITING · NA
-
Reproductive Axis Maturation in the Early Post-Menarchal Years
RECRUITING
-
Hospital-to-Home Transitional Care Interventions (H2H-TCI) Children/Youth With Special Health Care Needs (CYSHCN)
RECRUITING · NA
-
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
RECRUITING · Phase 1
-
A Clinical Trial to Study the Feasibility and Acceptability of an App to Support Pediatric Resuscitation
RECRUITING · NA
-
Tele-PCIT for Healthy Relationships in Families At-Risk
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI